NCT01682499View on ClinicalTrials.gov

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Paclitaxel-induced Neuropathy
Interventions
DRUG

calcium gluconate and magnesium sulfate

Intravenous calcium gluconate and magnesium sulfate, 1g each agent in 100 ml D5W over 30 minutes, immediately before and after each dose of paclitaxel

Trial Locations (3)

10003

Beth Israel Medical Center, New York

10011

Beth Israel Comprehensive Cancer Center, New York

10019

St. Luke's Roosevelt Hospital Center, New York

All Listed Sponsors
collaborator

St. Luke's-Roosevelt Hospital Center

OTHER

lead

Beth Israel Medical Center

OTHER

NCT01682499 - Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy | Biotech Hunter | Biotech Hunter